Skip to main content
Fig. 4 | Clinical Proteomics

Fig. 4

From: A multiplex immunoassay of serum biomarkers for the detection of uveal melanoma

Fig. 4

Analysis of biomarkers in sera from UM patients and healthy controls. a–g expression of OPN, MIA, CEACAM-1, MIC-1, SPON1, POSTN, and HSP27 in UM patients who either remained disease-free (DF) for at least 5 years after treatment for primary UM, patients who died with clinically overt metastases from UM, ptients in whom relavant clinicopathologic information was not available (NA), and healthy controls. Bars indicate median value

Back to article page